Business Daily from THE HINDU group of publications
Friday, Jun 22, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Mergers & Acquisitions
PerkinElmer buys 100% in Indian arm

Our Bureau

Acquires remaining 49% stake from Labindia


Growth plans
Expects to be able to react faster to changing local requirements.
Looking to set-up a technical support and application centre.
Research leaning of pharma industry fuelling growth optimism.

Mumbai June 21 Technology-provider for the life-sciences, analytical services and genetic screening segments, the United States-based PerkinElmer Inc, has acquired the remaining 49 per cent minority interest in PerkinElmer India Pvt Ltd from Labindia Instruments Pvt Ltd.

The transaction establishes PerkinElmer India Ltd as a wholly-owned subsidiary of PerkinElmer. However, no financial details were divulged by company officials. PerkinElmer had entered into the joint venture with Labindia in 2004.

Explaining the recent development, Mr Jai Shankar, the newly-appointed President of PerkinElmer India, said that the company sees growth in the Indian market and expects to be able to react faster to the changing local requirements.

The company is also looking to set-up a technical support and application centre, where companies can get a demonstration of the new technology that they may want to pick up, he said. The centre is expected to be in place by the third quarter of this year.

Research options

The increasing research-orientation of the pharmaceutical industry, besides expanding operations of contract research organisations, fuel PerkinElmer's optimism for the Indian growth market, he indicated.

With trace-detection being critical for several segments of industry, he pointed out that the technology offered by them found customers in food, bio-fuels, forensics and environment. The size of the domestic market targeted by the technology products from the company is about $350 million, he said.

PerkinElmer India at present employs approximately 170 people in Bangalore, Baroda, Chennai, Hyderabad, Kolkata, Mumbai, New Delhi, Pune and Thane, a note from the company said.

More Stories on : Mergers & Acquisitions | Pharmaceuticals | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Sony Ericsson setting up R&D unit in Chennai


HealthCare Global to launch 2 cancer drugs
BEML making stainless steel metro coaches for Mumbai, Kolkata
No intention to withdraw Ikon, says Ford
Varun Shipping buys VLCC
Tantia Const net rises to Rs 13 cr
L&T to build 2 ships for Dutch co BigLift
Mahindra Shaan wins global prize for innovative design in engg
`Efficacy' factor will be key to Glivec patent case
Cabinet allows Mittal to pick up 49% stake in Bhatinda refinery
Danone stake sale talk boosts Britannia stock
PerkinElmer buys 100% in Indian arm
Batliboi buys 70% stake in French co
Finolex Ind in deal with Tishman Speyer for land sale
Land allotment for Jindal plant flayed
Essar Global completes Canada's Algoma buy
NRB Bearings setting up plant in Thailand
IHC in pact with Jalan to set up Gateway hotel
Grindwell ties up with Singye
Tata Motors initiates health camp in Singur
Microsoft ad platform targets social network sites
Fenesta capacity to be doubled
Reliance Money claims `good' client base
Apeejay Surrendra group plans string of hotels
Schwing Stetter sees robust demand for ready mix concrete
GAIL to complete Dahej-Uran-Dabhol pipeline by June 30


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line